{"version":"1.0","type":"link","title":"BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.","author_name":"Jurczak W 외","author_url":"https://prs-insight.online/author/Jurczak%20W","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/161539","thumbnail_width":1200,"thumbnail_height":630}